Acetic Acid for Optical Characterization of Colonic Polyps
ATOMIC I
1 other identifier
interventional
55
1 country
1
Brief Summary
Adenomas and hyperplastic polyps are polypoid lesions that can occur in any part of the colon. Currently all polyps should be resected endoscopically, however adenomas have the potential to develop into colorectal cancer whereas hyperplastic polyps do not. This approach enables the lesions to be evaluated under the microscope. Currently only the pathological diagnosis can distinguish exactly between adenomas and hyperplastic polyps. Acetic acid (AA) chromoendoscopy is already widely used in order to improve optical determination of mucosal lesions in the upper gastrointestinal tract. In the colon only few studies investigated the impact of AA in differentiating normal mucosa from suspicious mucosa. The aim of the present study is to evaluate the value of spraying acetic acid as an adjunct for optical characterization of colon polyps. Using AA may be beneficial for determining optical diagnoses of colon polyps during real time colonoscopy. This is a single-arm proof of principle study. If colon polyps are found during colonoscopy a 1.5 percent AA solution will be used for chromoendoscopy. Endoscopists are encouraged to use the Narrow Band Imaging (NBI) function of the endoscope prior to the use of AA. After AA is sprayed endoscopists will diagnose the polyp optically. Endoscopists have to predict adenomatous or non-adenomatous histology based upon optical features of the polyp. All polyps will be resected endoscopically so that histopathological diagnoses can be determined. After completing the trial the investigators aim to compare optical and histopathological-based diagnoses of polyps. Histopathological diagnoses will serve as the gold standard. Based upon this information the accuracy of the optical diagnoses will be calculated. The investigators hypothesis is, that optical-based diagnosis using NBI and AA will be accurate in \> 75% of all polyp cases.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 23, 2016
CompletedStudy Start
First participant enrolled
May 1, 2016
CompletedFirst Posted
Study publicly available on registry
May 3, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2017
CompletedApril 11, 2017
April 1, 2017
6 months
April 23, 2016
April 8, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Diagnostic test: Optical characterization of colon polyps
Optical diagnosis of polyp histology will be assessed within a period of 2 weeks
up to 2 weeks
Study Arms (1)
Routine colonoscopy Cohort
EXPERIMENTALPatients receiving routine colonoscopy receive the intervention: NBI + Acetic Acid (AA)
Interventions
Patients belonging to the Routine colonoscopy Cohort will receive NBI + Acetic Acid (AA) chromoendoscopy for optical predictions of colonic polyps.
Eligibility Criteria
You may qualify if:
- indication for colonoscopy
You may not qualify if:
- pregnant women
- emergency investigation
- history of inflammatory bowel disease
- contraindication for polyp resection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
II Medizinische Klinik am Klinikum rechts der Isar der Technischen Universität München München, Deutschland Germany
Munich, Bavaria, 81675, Germany
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 23, 2016
First Posted
May 3, 2016
Study Start
May 1, 2016
Primary Completion
November 1, 2016
Study Completion
August 1, 2017
Last Updated
April 11, 2017
Record last verified: 2017-04
Data Sharing
- IPD Sharing
- Will not share